1. Biochemistry and Chemical Biology
  2. Cell Biology
Download icon

Structural and kinetic analysis of the COP9-Signalosome activation and the cullin-RING ubiquitin ligase deneddylation cycle

  1. Ruzbeh Mosadeghi
  2. Kurt M Reichermeier
  3. Martin Winkler
  4. Anne Schreiber
  5. Justin M Reitsma
  6. Yaru Zhang
  7. Florian Stengel
  8. Junyue Cao
  9. Minsoo Kim
  10. Michael J Sweredoski
  11. Sonja Hess
  12. Alexander Leitner
  13. Ruedi Aebersold
  14. Matthias Peter
  15. Raymond J Deshaies
  16. Radoslav I Enchev  Is a corresponding author
  1. University of Southern California, United States
  2. California Instittute of Technology, United States
  3. Swiss Federal Institute of Technology, Switzerland
  4. University of Konstanz, Germany
  5. California Institute of Technology, United States
  6. ETH Zurich, Switzerland
Research Article
  • Cited 45
  • Views 3,295
  • Annotations
Cite this article as: eLife 2016;5:e12102 doi: 10.7554/eLife.12102

Abstract

The COP9-Signalosome (CSN) regulates cullin-RING ubiquitin ligase (CRL) activity and assembly by cleaving Nedd8 from cullins. Free CSN is autoinhibited, and it remains unclear how it becomes activated. We combine structural and kinetic analyses to identify mechanisms that contribute to CSN activation and Nedd8 deconjugation. Both CSN and neddylated substrate undergo large conformational changes upon binding, with important roles played by the N-terminal domains of Csn2 and Csn4 and the RING domain of Rbx1 in enabling formation of a high affinity, fully active complex. The RING domain is crucial for deneddylation, and works in part through conformational changes involving insert-2 of Csn6. Nedd8 deconjugation and re-engagement of the active site zinc by the autoinhibitory Csn5 glutamate-104 diminish affinity for Cul1/Rbx1 by ~100-fold, resulting in its rapid ejection from the active site. Together, these mechanisms enable a dynamic deneddylation-disassembly cycle that promotes rapid remodeling of the cellular CRL network.

Article and author information

Author details

  1. Ruzbeh Mosadeghi

    Keck School of Medicine, University of Southern California, Los Angeles, United States
    Competing interests
    No competing interests declared.
  2. Kurt M Reichermeier

    Division of Biology and Biological Engineering, California Instittute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  3. Martin Winkler

    Department of Biology, Institute of Biochemistry, Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    No competing interests declared.
  4. Anne Schreiber

    Department of Biology, Institute of Biochemistry, Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    No competing interests declared.
  5. Justin M Reitsma

    Division of Biology and Biological Engineering, California Instittute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  6. Yaru Zhang

    Division of Biology and Biological Engineering, California Instittute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  7. Florian Stengel

    Department of Biology, University of Konstanz, Konstanz, Germany
    Competing interests
    No competing interests declared.
  8. Junyue Cao

    Division of Biology and Biological Engineering, California Instittute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  9. Minsoo Kim

    Division of Biology and Biological Engineering, California Instittute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  10. Michael J Sweredoski

    Proteome Exploration Lab, Beckman Institute, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  11. Sonja Hess

    Proteome Exploration Lab, Beckman Institute, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  12. Alexander Leitner

    Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zürich, Switzerland
    Competing interests
    No competing interests declared.
  13. Ruedi Aebersold

    Department of Biology, Institute of Molecular Systems Biology, Swiss Federal Institute of Technology, Zürich, Switzerland
    Competing interests
    No competing interests declared.
  14. Matthias Peter

    Department of Biology, Institute of Biochemistry, Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    No competing interests declared.
  15. Raymond J Deshaies

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States
    Competing interests
    Raymond J Deshaies, Reviewing editor, eLife.
  16. Radoslav I Enchev

    Department of Biology, Institute of Biochemistry, Swiss Federal Institute of Technology, Zurich, Switzerland
    For correspondence
    radoslav.enchev@bc.biol.ethz.ch
    Competing interests
    No competing interests declared.

Reviewing Editor

  1. J Wade Harper, Harvard Medical School, United States

Publication history

  1. Received: October 5, 2015
  2. Accepted: March 30, 2016
  3. Accepted Manuscript published: March 31, 2016 (version 1)
  4. Accepted Manuscript updated: April 2, 2016 (version 2)
  5. Version of Record published: May 23, 2016 (version 3)

Copyright

© 2016, Mosadeghi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,295
    Page views
  • 994
    Downloads
  • 45
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Biochemistry and Chemical Biology
    Sandy Mattijssen et al.
    Research Advance Updated

    La-related protein 4 (LARP4) directly binds both poly(A) and poly(A)-binding protein (PABP). LARP4 was shown to promote poly(A) tail (PAT) lengthening and stabilization of individual mRNAs presumably by protection from deadenylation (Mattijssen et al., 2017). We developed a nucleotide resolution transcriptome-wide, single molecule SM-PAT-seq method. This revealed LARP4 effects on a wide range of PAT lengths for human mRNAs and mouse mRNAs from LARP4 knockout (KO) and control cells. LARP4 effects are clear on long PAT mRNAs but become more prominent at 30–75 nucleotides. We also analyzed time courses of PAT decay transcriptome-wide and for ~200 immune response mRNAs. This demonstrated accelerated deadenylation in KO cells on PATs < 75 nucleotides and phasing consistent with greater PABP dissociation in the absence of LARP4. Thus, LARP4 shapes PAT profiles throughout mRNA lifespan with impact on mRNA decay at short lengths known to sensitize PABP dissociation in response to deadenylation machinery.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Ali Alghamdi et al.
    Research Article

    Mutations in the Trypanosoma brucei aquaporin AQP2 are associated with resistance to pentamidine and melarsoprol. We show that TbAQP2 but not TbAQP3 was positively selected for increased pore size from a common ancestor aquaporin. We demonstrate that TbAQP2's unique architecture permits pentamidine permeation through its central pore and show how specific mutations in highly conserved motifs affect drug permeation. Introduction of key TbAQP2 amino acids into TbAQP3 renders the latter permeable to pentamidine. Molecular dynamics demonstrates that permeation by dicationic pentamidine is energetically favourable in TbAQP2, driven by the membrane potential, although aquaporins are normally strictly impermeable for ionic species. We also identify the structural determinants that make pentamidine a permeant although most other diamidine drugs are excluded. Our results have wide-ranging implications for optimising antitrypanosomal drugs and averting cross-resistance. Moreover, these new insights in aquaporin permeation may allow the pharmacological exploitation of other members of this ubiquitous gene family.